Cambridge Investment Research Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Sell
27,566
-4,034
-13% -$369K 0.01% 1353
2026
Q1
$1.17M Sell
31,600
-880
-3% -$28.1K ﹤0.01% 2025
2025
Q4
$656K Sell
32,480
-20,500
-39% -$496K ﹤0.01% 2469
2025
Q3
$1.59M Buy
52,980
+18,585
+54% +$402K ﹤0.01% 1683
2025
Q2
$445K Buy
34,395
+8,393
+32% +$79.9K ﹤0.01% 2650
2025
Q1
$190K Sell
26,002
-1,575
-6% -$17.4K ﹤0.01% 3220
2024
Q4
$459K Buy
27,577
+8,350
+43% +$111K ﹤0.01% 2498
2024
Q3
$247K Buy
+19,227
New +$278K ﹤0.01% 2979

Other funds holding AEHR

Cambridge Investment Research Advisors's AEHR Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Aehr Test Systems (AEHR) stake by 13% in Q2 2026, selling an estimated $369K and leaving 27,566 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #1353.

Cambridge Investment Research Advisors first reported a position in AEHR in Q3 2024 and has held it in 8 quarters since. 45 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Cambridge Investment Research Advisors held 27,566 shares of Aehr Test Systems worth $2.65M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 4,034 Aehr Test Systems shares in Q2 2026, an estimated $369K.
  • Aehr Test Systems made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1353 holding.
  • Cambridge Investment Research Advisors first reported a position in Aehr Test Systems in Q3 2024 and has held it in 8 quarters since.
  • 45 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.